Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Prognostic value of the MicroRNA regulators Dicer and Drosha in non-small-cell lung cancer: co-expression of Drosha and miR-126 predicts poor survival.

Lønvik K, Sørbye SW, Nilsen MN, Paulssen RH.

BMC Clin Pathol. 2014 Dec 11;14(1):45. doi: 10.1186/1472-6890-14-45. eCollection 2014.

2.

HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.

Sørbye SW, Fismen S, Gutteberg TJ, Mortensen ES, Skjeldestad FE.

PLoS One. 2014 Nov 18;9(11):e112934. doi: 10.1371/journal.pone.0112934. eCollection 2014.

3.

Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer.

Cui G, Qi H, Gundersen MD, Yang H, Christiansen I, Sørbye SW, Goll R, Florholmen J.

Cancer Immunol Immunother. 2015 Feb;64(2):181-90. doi: 10.1007/s00262-014-1624-x. Epub 2014 Oct 17.

PMID:
25324197
4.

The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk.

Kilvaer TK, Smeland E, Valkov A, Sorbye SW, Bremnes RM, Busund LT, Donnem T.

BMC Clin Pathol. 2014 Jan 20;14(1):5. doi: 10.1186/1472-6890-14-5.

5.

Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas.

Sorbye SW, Kilvaer TK, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

BMC Clin Pathol. 2013 Mar 15;13:9. doi: 10.1186/1472-6890-13-9.

6.

Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.

Sorbye SW, Kilvaer TK, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

PLoS One. 2012;7(10):e47068. doi: 10.1371/journal.pone.0047068. Epub 2012 Oct 5.

7.

HPV mRNA testing in triage of women with ASC-US cytology may reduce the time for CIN2+diagnosis compared with repeat cytology.

Sørbye SW, Fismen S, Gutteberg TJ, Mortensen ES, Skjeldestad FE.

Curr Pharm Des. 2013;19(8):1401-5.

PMID:
23016772
8.

High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator.

Sorbye SW, Kilvaer T, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

Oncoimmunology. 2012 Jan 1;1(1):75-77.

9.

Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas.

Sorbye SW, Kilvaer TK, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

BMC Clin Pathol. 2012 May 3;12:7. doi: 10.1186/1472-6890-12-7.

10.

Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas.

Sorbye SW, Kilvaer TK, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

BMC Clin Pathol. 2012 Feb 29;12:5. doi: 10.1186/1472-6890-12-5.

11.

[HPV test in the prevention of cervix cancer].

Sørbye SW, Fismen S, Gutteberg TJ, Mortensen E.

Tidsskr Nor Laegeforen. 2012 Feb 21;132(4):396-7. doi: 10.4045/tidsskr.11.0976. Norwegian. No abstract available.

12.

The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas.

Valkov A, Kilvaer TK, Sorbye SW, Donnem T, Smeland E, Bremnes RM, Busund LT.

J Transl Med. 2011 Nov 22;9:200. doi: 10.1186/1479-5876-9-200.

13.

HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy.

Sørbye SW, Arbyn M, Fismen S, Gutteberg TJ, Mortensen ES.

PLoS One. 2011;6(10):e26022. doi: 10.1371/journal.pone.0026022. Epub 2011 Oct 6.

14.

Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology.

Sørbye SW, Arbyn M, Fismen S, Gutteberg TJ, Mortensen ES.

PLoS One. 2011;6(8):e24083. doi: 10.1371/journal.pone.0024083. Epub 2011 Aug 30.

15.

Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.

Kilvaer TK, Valkov A, Sorbye SW, Smeland E, Bremnes RM, Busund LT, Donnem T.

J Transl Med. 2011 Jul 6;9:104. doi: 10.1186/1479-5876-9-104.

16.

The prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomas.

Valkov A, Sorbye SW, Kilvaer TK, Donnem T, Smeland E, Bremnes RM, Busund LT.

PLoS One. 2011 Mar 3;6(3):e17507. doi: 10.1371/journal.pone.0017507.

17.

Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival.

Kilvaer TK, Valkov A, Sorbye SW, Donnem T, Smeland E, Bremnes RM, Busund LT.

Sarcoma. 2010;2010:751304. doi: 10.1155/2010/751304. Epub 2011 Jan 23.

18.

Prognostic impact of lymphocytes in soft tissue sarcomas.

Sorbye SW, Kilvaer T, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

PLoS One. 2011 Jan 27;6(1):e14611. doi: 10.1371/journal.pone.0014611.

19.

Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival.

Donnem T, Lonvik K, Eklo K, Berg T, Sorbye SW, Al-Shibli K, Al-Saad S, Andersen S, Stenvold H, Bremnes RM, Busund LT.

Cancer. 2011 Jul 15;117(14):3193-200. doi: 10.1002/cncr.25907. Epub 2011 Jan 24.

20.

Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization.

Donnem T, Eklo K, Berg T, Sorbye SW, Lonvik K, Al-Saad S, Al-Shibli K, Andersen S, Stenvold H, Bremnes RM, Busund LT.

J Transl Med. 2011 Jan 10;9:6. doi: 10.1186/1479-5876-9-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk